642.80
+10.20
+(1.61%)
At close: 3:30:34 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-420,327.00
-862,807.00
-606,812.00
-398,463.00
Investing Cash Flow
--
308,210.00
-461,184.00
-347,070.00
344,692.00
Financing Cash Flow
--
1,336,727.00
843,757.00
1,121,342.00
833,003.00
End Cash Position
--
2,048,844.00
800,740.00
1,334,676.00
1,216,803.00
Capital Expenditure
--
-43,812.00
-103,823.00
-121,434.00
-5,139.00
Issuance of Capital Stock
--
1,196,731.00
760,953.00
1,091,326.00
813,186.00
Repayment of Debt
--
-3,801.00
-4,165.00
-3,855.00
-2,550.00
Free Cash Flow
--
-464,139.00
-966,630.00
-728,246.00
-403,602.00
12/31/2020 - 9/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4DN.F Denali Therapeutics Inc.
22.59
+0.89%
22Z.F Zealand Pharma A/S
99.60
+2.57%
TRGNF Transgene SA
1.5900
0.00%
UNC.MU UCB SA
188.20
-0.74%
ABVX.PA ABIVAX Société Anonyme
6.04
+2.90%
GNTA Genenta Science S.p.A.
3.5200
-15.18%
NWRN.SW Newron Pharmaceuticals S.p.A.
9.46
+0.42%
IDIA.SW Idorsia Ltd
0.7040
-1.61%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
SPRO Spero Therapeutics, Inc.
0.8566
-1.54%